Target animal species:

Sheep, goats, catle and camels.

Active substance:

1 dose (2 ml) of the vaccine contains:

Inactivated bacterial cultures:

• Clostridium perfringens type A and alfa toxoid (≥ 2,5 IU anti-alpha*)
• Clostridium perfringens type C and beta toxoid (≥ 10 IU anti-beta*)
• Clostridium perfringens type D and epsilon toxoid (≥ 5 IU anti-epsilon*)
• Clostridium novyi type B and toxoid (≥ 3,5 IU anti-novyi*)
• Clostridium septicum and toxoid (≥ 2,5 IU anti-septicum*)
• Fusobacterium necrophorum (≥ 40 AU*)
• Staphylococcus aureus (≥ 0,5 AHU*)
• Arcanobacterium pyogenes (≥ 80 AU.*)

* antibodies titer in ml of serum

* AU- agglutinating unit

* AHU – antihemolytic unit

Indications:

Active immunization of target animal species against infection caused by Clostridium perfringens, types A, C and D, Clostridium septicum, Clostridium novyi type B, Fusobacterium nechrophorum, Staphylococcus aureus and Arcanobacterium pyogenes.

At least 14 days after revaccination titer reaches its highest level (second dose of vaccine).

According to field trials data, the immunity lasts for at least one year.

Amounts to be administered and administration route:

Sheep and lambs: 2 mL

Goats and kids: 2 mL

Cattle and calves: 5 mL

Camels: 5 mL

The vaccine is administered exclusively subcutaneously into the knee fold, the neck area or the chest behind the blade (for sheep and goats) and the neck area (for cattle and camels), using the principles of asepsis and antisepsis (injection administered at the site where the skin is clean and dry, to avoid the possibility of infection).

Primary vaccination: administer two doses within an interval of 3 weeks (21 days)

Booster vaccination: administer one dose every 12 months.

Withdrawal period:

Zero (0) days.

Packaging:

Bottle, 100 mL

Bottle, 250 mL

* not registered for all target animal species in all territories

* not all pack sizes may be marketed

Target animal species:

Pigeons.

Active substance:

1 dose (1 mL) of vaccine contains:

• Salmonella typhimurium var. Copenhagen min. 40 A.U./mL

Indications:

Active immunization of pigeons against infections caused by Salmonella typhimurium var. Copenhagen.

Amounts to be administered and administration route:

For subcutaneous (s.c.) use.The vaccine is administered subcutaneously in the neck at a dose of 1 mL, twice in the period of 14 days.

Withdrawal period:

Zero (0) days.

Presentation:

Bottle 50 mL (50 doses)

Target animal species:

Pigs.

Active substance

• Inactivated bacteria Erysipelothrix rhusiopathiae

Indications for use

Active immunization of pigs against swine erysipelas (diamond skin disease).

Amounts to be administered and administration route:

The dosage of the vaccine is 2 mL.The vaccine is administered once s.c. (behind the ear) at the dosage of 2 mL. All healthy animals over the age of 3 months are vaccinated. Depending on the epizootological situation, vaccination can be performed on individuals younger than 3 months and on piglets not more than 3 weeks old. Individuals vaccinated at the age younger than 3 months should be revaccinated 6 - 8 weeks later after the first vaccination. Pregnant sows are vaccinated in the first third of pregnancy, and revaccinated 5-6 weeks after the parturition.

Withdrawal period:

Zero (0) days.

Presentation:

Bottle 100 mL (50 doses)

Target animal species:

Chickens and turkey poults.

Active substance:

1 dose of the vaccine contains:

• Live lentogenic Newcastle disease virus, La Sota strain 106,0 - 107,0 EID50

Indications

Active immunization of chickens and poults against Newcastle disease.

Amounts to be administered and administration route:

For oculo-nasal application and aerosol application

Oculo-nasal application:

0,1 mL i.e. two drops of the vaccine after reconstitution in a suitable solvent

Aerosol application:

1000 doses of the vaccine should be dissolved in 250 mL of distilled water.

Withdrawal period

Zero (0) days.

Presentations:

1 vial with lyophilisate (25 doses) and 1 vial with solvent (2,5 mL)

1 vial with lyophilisate (50 doses) and 1 vial with solvent (5 mL)

5 vials with lyophilisate (5 x 1000 doses) and 5 vials with solvent (5 x 100 mL)

5 vials with lyophilisate (5 x 2000 doses) and 10 vials with solvent (10 x 100 mL)

Target animal species:

Laying hens prior to onset of laying.

Active substance:

One 0.5 mL dose of the vaccine contains:

• Inactivated virus of the Newcastle disease, La Sota strain: HI titer* ≥4 log 2

*antibody titer in the serum of vaccinated chickens determined by applying the hemagglutination inhibition method

Indications:

Active immunization against the Newcastle disease (atypical avian influenza).

The time needed for immunity to develop: 3 weeks.

The duration of immunity: immunity lasts until the end of the production cycle.

Amounts to be administered and administration route:

For intramuscular use.The vaccine is administered intramuscularly in the chest, in the dose of 0.5 mL.The vaccine is given to birds when they are between 16 and 20 weeks old, but not later than 3 weeks before the laying of eggs is expected. Prior to administering the PEST-ol® vaccine, birds should be immunized with live vaccine against atypical avian influenza (Lasovak®). The period between administering the live vaccine and the PEST-ol® vaccine should be at least 2 weeks. Best results are achieved if that period is 6 weeks or more.

Withdrawal period:

Zero (0) days

Presentation:

Bottle 50 mL (100 doses)

Target animal species:

Chickens.

Active substance:

1 dose (0,5 mL) of vaccine contains:

• Inactivated Newcastle disease virus (strain La Sota) ≥ 6 log 2 HU/dose
• Inactivated Infectious bronchitis virus (strain H52) ≥ 6 log 2 HU/dose
• Inactivated virus of Egg drop syndrome (strain BC14) ≥ 5 log 2 HU/dose

Indications:

Active immunization of breeder and layer pullets against of Egg drop syndrome, Infectious bronchitis ad Newcastle disease.

Period required for develop of immunity: 3 weeks.

Duration of immunity: immunity lasts until the end of the production cycle.

Amounts to be administered and administration route:

1 dose of vaccine is 0.5 mL. The vaccine is administered s.c. in the neck or i.m. into the pectoral musculature. Poultry are vaccinated at the age of 16-18 weeks, ie. not less than 4 weeks before the expected laying egg. Before using BRONED-OL® vaccine, chickens must be vaccinated with live vaccines against infectious bronchitis and Newcastle disease. The time between the administration of live vaccine and booster vaccination with BRONED-OL® vaccine should not be less than 2 weeks. The best booster effect is achieved 6 weeks after the live vaccine.

Withdrawal period:

Zero (0) days

Presentation:

Bottle 250 mL (500 doses)

Target animal species:

Pigs.

Active substance:

1 dose (1ml) of vaccine contains:

• Live attenuated classical swine fever virus (China strain) minimum 100 PD50

Indications:

Active immunization against classical swine fever.

Amounts to be administered and administration route:

The vaccine is applied intramuscularly in a 1ml dose, regardless of the age of the pig. After reconstitution in an appropriate amount of the enclosed solvent (1 dose is reconstituted in 1mL of solvent), the vaccine is only applied intramuscularly, namely in the inside of the thigh for younger categories, and in the neck musculature for adult animals.

Withdrawal period:

Zero (0) days.

Presentations:

5 vials x 10 doses of vaccine and 5 vials x 10 mL of solvent.

5 vials x 20 doses of vaccine and 5 vials x 20 mL of solvent.

Target animal species:

Pigs.

Active substance:

One dose (1ml) of reconstituted vaccine contains:

• Live attenuated virus of Aujeszky’s disease (Bartha strain), 103,5 – 105,0 TCID50

Indications:

Active immunization of healthy pigs and piglets against Aujeszky’s disease.

The immunity is developed within 14 days and after revaccination, animal protection lasts one year.

Amounts to be administered and administration route:

The vaccine needs to be applied subcutaneously in the amount of 1mL for all categories of pigs. All piglets shall be vaccinated when they are 5 weeks old, at the earliest, and shall be revaccinated after 2-3 weeks The immunity is developed within 14 days and after revaccination, animal protection lasts 12 months.

Withdrawal period:

Zero (0) days

Presentation:

5 vials x 20 doses of vaccine and 5 vials x 20 mL of solvent.